Riskpilot← Back to searchSign inGet full accessDr Flasch AB
ABIn liquidationOrg 5593784654FalunMedical specialists activities · NACE 8622Est. 20221 employees
Revenue 2025
SEK 0
EBITDA margin
—
-113% vs 2024
Equity ratio
-5.7%
Financial strength
Net profit 2025
SEK -42K
-118% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -41K | -113% |
| Net profit | SEK -42K | -118% |
| Total assets | SEK 70K | -89% |
| Equity | SEK -4K | -101% |
| Employees | 1 | — |
Legal name
Dr Flasch AB
Org number
5593784654
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 maj 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn externa firmatecknarna
Company purpose
Bolaget ska utföra läkartjänster och utbildning inom offentlig och privat sjukvård och därmed förenlig verksamhet. Bolaget ska också organisera utbildningar och evenemang inom friskvård, hälsa, näringslära och yoga och därmed förenlig verksamhet samt konsultverksamhet inom beskrivna verksamhetsområden. Samt äga, förvalta fast egendom inom fastighetsbranschen samt äga och förvalta värdepapper och därmed förenlig verksamhet.
Address
Falun
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 1 016 | 785 | 0 |
| Staff expenses | −821 | −379 | −4 |
| EBITDA | 182 | 307 | −41 |
| Depreciation & amort. | — | — | — |
| EBIT | 182 | 307 | −41 |
| Net financials | −0 | −1 | −1 |
| Profit before tax | 181 | 305 | −42 |
| Tax | −38 | −66 | — |
| Net profit | 144 | 239 | −42 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 534 | 632 | 70 |
| Equity | 169 | 338 | −4 |
| Long-term debt | — | — | — |
| Short-term debt | 365 | 294 | 74 |
| Total debt | 365 | 294 | 74 |
EBITDA margin
-4127800.0%
This company
15.8%
Market median
-26125416% vs market
20232025
Equity ratio
-5.7%
This company
38.2%
Market median
-115% vs market
20232025
Return on equity
-4208700.0%
This company
18.4%
Market median
-22873470% vs market
20232025
Net profit margin
-4208700.0%
This company
8.1%
Market median
-51959359% vs market
20232025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232025
Debt / equity
18.46×
This company
0.62×
Market median
-2877% vs market
20232025
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
BJ External Signatory | External Signatory | 2026 |
KO Liquidator | Liquidator | 2026 |
AE External Signatory | External Signatory | 2026 |
UM External Signatory | External Signatory | 2026 |
EJ External Signatory | External Signatory | 2026 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr Flasch AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt Junior Niklas Nygårds | External Signatory | 0 companies |
| Knut Olof Mikael Rosén | Liquidator | 0 companies |
| Anna Elisabet Viktoria Björk | External Signatory | 0 companies |
| Ulrika Margareta Ahlholm | External Signatory | 0 companies |
| Emma Johanna Karin Carlstedt Haga | External Signatory | 0 companies |
| Adina Rebecca Flaschner | Board of Directors | 0 companies |
| Maria Rosenqvist Flaschner | Deputy Board Member | 0 companies |